biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by roadking08on Aug 05, 2016 9:33pm

118 Views

Post# 25116014

I want to whine too...but sure smells good

lovincoal would like to know the anonymous seller..

jd sure would like to know who's buying

jr would like to know what to make of the huge level II bid on the States side, though with a very slight haircut, still there by the way.

roadking would love for the windling supply side to be taken away by the getting bigger by the moment demand side.

In ten years from now, like Brian Williams would like to say anchoring on NBC news, "I was there"

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta